A novel series of microbial metabolites were discovered in fermentation broths of two soil isolates. Both cultures were identified as strains of Micromonospora chalcea. Production of the metabolites, named macquarimicins, was monitored by an HPLCassay. A seven-day fermentation yielded 27mg/liter of macquarimicin A. With MICs of 50 to 100//g/ml, macquarimicin A has only very low activity against strains of Bacteroides and other anaerobes. Macquarimicin B has inhibitory activity against the leukemia cell line P-388.
B. thetaiotamicron are found in most abdominal infections and may be seen in infections at other sites. The Bacteroides group is more resistant than most other anaerobes to available antimicrobial agentsX). Weused B. fragilis as the primary target organism in screening microbial metabolites for agents which inhibit anaerobic bacteria. Fromthis screen we found two microorganisms producing a family of novel compounds. This paper will describe the production of the agents by fermentation, the identification of the producing microorganisms and the biological activity of the macquarimicins. A companion paper will describe the isolation of the active components and the elucidation of their chemical struc-tures2).
Materials and Methods

Microorganisms
Micromonospora strain AB 965S-73 was isolated from a soil sample collected on a construction site at Macquarie University in Sydney, Australia. The second producer, Micromonospora sp. AB 969J-62, was from soil collected in Henrico County, Virginia, U.S.A. The Micromonospora neotype strain, M. chalcea ATCC 12452, was obtained from the American Type Culture Collection. The bacteria used to characterize the activity of macquarimicin A were from the ATCCand from our laboratory collection.
TaxonomicStudies JUNE 1995 The producers of macquarimicin were compared with the Micromonosporaneotype strain on media described by Shirling and Gottlieb3) and by Waksman4) and on ATCCmedium 172 with incubation at 28°C for 22 days. Color names were assigned to the mycelial growth and to the spore masses on the basis of the Inter-Society was prepared in distilled water, and the pH was adjusted to 7.3. The fermentor was charged with 70 liters of mediumand sterilized in place for 1 hour at 121°C and 1.05 kg/cm2. Agitation was 200rpm, and aeration was 0.7vol/vol/minute. A head pressure of 0.35 kg/cm2 was maintained. Antifoam, XFO-371 (Ivanhoe Chemical), was added initially at 0.01%and then was available on demand. The fermentation was harvested on the 7th day.
Analysis of Fermentation Samples
Macquarimicin production was analyzed by HPLC. A 4.6x250mm column packed with Spherisorb 5 C-8 (Phenomenex) was eluted with 0.1% H3PO4-CH3CN (70:30) at pH 3. The flow rate was 1ml/minute. Fermentation broth samples were prepared for assay by extraction with ethyl acetate. The solvent was removed in vacuo, and methanol was added to give a 100-fold concentration with respect to the broth. The methanol sample was filtered through an HPLCsyringe filter before injection. Detection was at 240nm. Growth was evaluated as packed cell volume by centrifuging the fermentation broth in a graduated conical tube at 600 x g for 20 minutes. Residual carbohydrate was determined by the phenol-sulfuric acid method of Dubois et al.10) .
Evaluation of Biological Activity
Minimal inhibitory concentrations (MICs) of macquarimicin were determined by the agar dilution method. Anaerobes were grown on Wilkins Chalgren agar incubated in a BBLGas-Pak anaerobic chamber at 37°C. Aerobes were grown on Mueller-Hinton agar. Inoculum concentration was 1 x 104 cells per inoculation. Plates were incubated for 24 hours. The MIC was determined as the lowest concentration of macquarimicin with not more than 4 colonies per inoculation spot. For assessment of potential antitumor activity, P-388 leukemia cells were maintained in RPMI1640 mediumsupplemented with 1 0%fetal bovine serum. The antiproliferative effect of the agents against P-388 cells was determined using an MTTcolorimetric method1 1*.
Results and Discussion
Strains AB 965S-73 and AB 969J-62 form welldeveloped, branched mycelia. Aerial hyphae were absent.
Non-motile spores are borne singly on monopodial sporophores (see Figs. 1 and 2) . The vegetative mycelium is orange on most media, and mature sporulation is brown to brownish black in color. The diaminopimelic acid found in whole-cell hydrolysates was the meso isomer.
The diagnostic sugars present were xylose and arabinose indicating cell wall type IID12). The morphology and cell wall type identify these strains as membersof the genus Micromonospora 1 3). The macquarimicin-producing strains were compared with the Micromonosporaneotype strain, M. chalcea ATCC12452. The cultural characteristics of Bar represents 2.0 /mi. the three cultures are given in Table 1 . The comparison of carbon source utilization is shown in Table 2 . The macquarimicin-producing strains were found to be sensitive to lysozyme as was M. chalcea. Menaquinone MK-10(H6) was found in extracts of AB 969J-62 while both MK-10(H4) and MK-10(H6) were in AB 965S-73 (see Table 3 ). These are the two most commonmenaquinones found among the micromonosporae. While the strains are not identical they have considerable phenotypic homology with each other and with M. chalcea. Weconsider both producing cultures to be Table 5 . Inhibitory activity of macquarimicins B and C against P-388.
Macquarimicin
IC 5 0 (jug/ml) strains of M. chalcea. A time course of the fermentation is shown in Fig. 3 . The HPLCassay was effective in quantitating macquarimicin A in crude fermentation samples. A yield of 27mg/liter macquarimicin A was obtained in a seven day fermentation. In addition to macquarimicin A, related compoundswere observed in fermentation broths of strain AB969J-62. Purified macquarimicin A, evaluated with a panel of anaerobic bacteria, gave disappointing results (Table 4 ).
MICs ranged from 50 to lOOjUg/ml against B. fragilis and B. thetaiotamicron and from 50 to >200//g/ml against other anaerobes. Macquarimicin had MICs> 100 /ig/ml against 22 Gram-positive and Gram-negative bacteria grown aerobically. Macquarimicins B and C were found to inhibit the leukemia cell line P-388 (Table   agent , albeit of low potency, and preliminarily reported as the first of a novel chemical class in 198614). Another family of the same structural type, the cochleamycins, have been discovered as antitumor agents from a streptomycete1 5). Re-examination of the macquarimicin fermentation yielded two new members of the family, B and C, which, like the cochleamycins, show activity against leukemia cell lines.
